Capacity

 

Over the past few years ISARIC has responded to MERS, Ebola, Zika, Monkeypox, Lassa fever, and to COVID-19. This has included preparing standardised data collection tools, a clinical trial of plague treatment regimens, an expanded access programme for a novel therapeutic for Monkeypox and writing & disseminating an observational protocol for emerging pathogens (CCP), which recently recruited for COVID-19, MERS, Acute Severe Hepatitis in Young Children and Monkeypox cases.

There is a critical need to empower clinical researchers in Low- and Middle-Income Countries (LMICs) to lead the research response to epidemic infections.  We have been building a portfolio of research capacity building initiatives, to support emerging clinical researchers in exchanging knowledge, gaining confidence in their research and leadership skills, developing local and regional research agendas, and ultimately increasing the international footprint of their institution both within ISARIC and further afield.

Collaboration is at the core of everything we do and our research capacity strengthening programmes focus on reaching out to, and working with a number of regional and international initiatives such as the ISARIC Career Development Fellowship Scheme, localised training initiatives e.g. Preparedness research/clinical research resources, Clinical REsearch During Outbreaks (CREDO) training curriculum, and our work in LMIC regional capacity building for the roll out and follow-up of COVID-19 patients using the Clinical Characterisation Protocol (CCP).

 

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Publication library

Visit this section to find ISARIC’s articles, studies and more.

Latest news

Draft Framework for Clinical Trials Now Open for Feedback

Draft Framework for Clinical Trials Now Open for Feedback

18 December 2023: The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) is working with partners to create a framework on endpoint selection for clinical trials for outbreak-prone infectious diseases. This call for a public consultation invites feedback on what the framework does well, what could be improved and the limits of its potential application.

ISARIC/RESPIRE Career Development Fellows Complete Global Placements

ISARIC/RESPIRE Career Development Fellows Complete Global Placements

16 November 2023: Three scientists who were awarded a Career Development Fellowship by the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) and the NIHR Global Health Research Unit on Respiratory Health (RESPIRE) have completed 2-week placements with research teams in Brazil and the Philippines.

The Pandemic Sciences Institute hosted the ‘Key Features of Technology Platforms for R&D to Rapidly Respond to New Outbreaks’ Webinar

The Pandemic Sciences Institute hosted the ‘Key Features of Technology Platforms for R&D to Rapidly Respond to New Outbreaks’ Webinar

The Pandemic Sciences Institute hosted the 'Key Features of Technology Platforms for R&D to Rapidly Respond to New Outbreaks' Webinar.